首页> 美国卫生研究院文献>Clinical Molecular Pathology >Immunohistochemistry in apparently normal bone marrow trephine specimens from patients with nodal follicular lymphoma.
【2h】

Immunohistochemistry in apparently normal bone marrow trephine specimens from patients with nodal follicular lymphoma.

机译:淋巴结滤泡性淋巴瘤患者看似正常的骨髓冰毒标本中的免疫组织化学。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM--To establish the role of immunohistochemistry (using a limited panel of antibodies) in detecting minimal involvement by follicular lymphoma in routinely processed bone marrow trephine specimens, which show no obvious morphological (light microscopic) evidence of lymphoma; to determine whether bcl-2 immunostaining in bone marrow distinguishes between benign and malignant infiltrates in a patient with nodal follicular lymphoma. METHODS--Twenty seven consecutively selected paraffin wax embedded, formalin fixed bone marrow trephine specimens were stained with the following antibodies: anti-bcl-2, anti-CD79a, anti-CD3, and kappa and lambda light chains, using the Streptavidin biotin complex technique. RESULTS--Five of the 27 cases, which showed no evidence of involvement by follicular lymphoma on routine stains, showed monotypic B cells on immunohistochemistry. Two of the cases were diffuse, while the remaining three showed mini-aggregates around bony trabeculae. In all five cases the lymphomatous infiltrates were strongly bcl-2 positive. Reactive B lymphoid nodules did not show the same degree of bcl-2 positivity, and negative cells could be discerned within the reactive nodules. CONCLUSIONS--There is merit in studying so-called negative bone marrows immunohistochemically in order to detect minimal involvement by follicular lymphoma. A limited panel of antibodies including anti-bcl-2, anti-CD79a and anti-CD3 is usually adequate to accomplish this. Strongly bcl-2 positive lymphoid aggregates in the bone marrow of patients with nodal follicular lymphoma are indicative of lymphoma.
机译:目的-建立免疫组织化学(使用有限的抗体组)在检测常规处理的骨髓环冰毒标本中滤泡性淋巴瘤的最小参与中的作用,这些标本没有明显的形态学(光学显微镜)证据表明淋巴瘤;确定淋巴结滤泡性淋巴瘤患者骨髓中bcl-2免疫染色是否能区分良性和恶性浸润。方法-使用链霉亲和素生物素复合物对27份连续选择的石蜡包埋的,用福尔马林固定的骨髓凝集素样本进行以下染色:抗bcl-2,抗CD79a,抗CD3以及kappa和lambda轻链。技术。结果-27例中有5例在常规染色上没有发现滤泡性淋巴瘤的证据,但在免疫组织化学上显示出单型B细胞。其中两例为弥漫性,其余三例在骨小梁周围呈微小聚集。在所有五种情况下,淋巴瘤浸润均为强bcl-2阳性。反应性B淋巴结节未显示相同程度的bcl-2阳性,并且在反应性结节内可辨别阴性细胞。结论-免疫组织化学研究所谓的阴性骨髓以检测滤泡性淋巴瘤的最小影响是有好处的。通常,包括抗bcl-2,抗CD79a和抗CD3在内的有限抗体通常足以实现此目的。淋巴结滤泡性淋巴瘤患者骨髓中强烈的bcl-2阳性淋巴样聚集体提示淋巴瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号